|
1
|
Grandhi MS, Kim AK, Ronnekleiv-Kelly SM,
Kamel IR, Ghasebeh MA and Pawlik TM: Hepatocellular carcinoma: From
diagnosis to treatment. Surg Oncol. 25:74–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu Y, Tang H, Zhang L, Gong L, Wu G, Ni J
and Tang X: Suppression of miR-21-3p enhances TRAIL-mediated
apoptosis in liver cancer stem cells by suppressing PI3K/Akt/Bad
cascade via regulating PTEN. Cancer Manag Res. 11:955–968. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balogh J, Victor D III, Asham EH,
Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM and Monsour
HP Jr: Hepatocellular carcinoma: A review. J Hepatocell Carcinoma.
3:41–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gomes MA, Priolli DG, Tralhao JG and
Botelho MF: Hepatocellular carcinoma: Epidemiology, biology,
diagnosis, and therapies. Rev Assoc Med Bras (1992). 59:514–524.
2013.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cidon EU: Systemic treatment of
hepatocellular carcinoma: Past, present and future. World J
Hepatol. 9:7972017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wiedmer T, Zhao J, Nanjundan M and Sims
PJ: Palmitoylation of phospholipid scramblase 1 controls its
distribution between nucleus and plasma membrane. Biochemistry.
42:1227–1233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou Q, Zhao J, Wiedmer T and Sims PJ:
Normal hemostasis but defective hematopoietic response to growth
factors in mice deficient in phospholipid scramblase 1. Blood.
99:4030–4038. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Y, Zhao Q, Zhou CX, Gu ZM, Li D, Xu
HZ, Wiedmer T, Sims PJ, Zhao KW and Chen GQ: Antileukemic roles of
human phospholipid scramblase 1 gene, evidence from inducible
PLSCR1-expressing leukemic cells. Oncogene. 25:6618–6627. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silverman RH, Halloum A, Zhou A, Dong B,
Al-Zoghaibi F, Kushner D, Zhou Q, Zhao J, Wiedmer T and Sims PJ:
Suppression of ovarian carcinoma cell growth in vivo by the
interferon-inducible plasma membrane protein, phospholipid
scramblase 1. Cancer Res. 62:397–402. 2002.PubMed/NCBI
|
|
10
|
Francis VG, Padmanabhan P and Gummadi SN:
Snail interacts with hPLSCR1 promoter and down regulates its
expression in IMR-32. Biochem Biophys Res Commun. 450:172–177.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vinnakota JM and Gummadi SN: Two c-Myc
binding sites are crucial in upregulating the expression of human
phospholipid scramblase 1 gene. Biochem Biophys Res Commun.
469:412–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou Q, Ben-Efraim I, Bigcas J, Junqueira
D, Wiedmer T and Sims PJ: Phospholipid scramblase 1 binds to the
promoter region of the inositol 1,4,5-triphosphate receptor type 1
gene to enhance its expression. J Biol Chem. 280:35062–35068. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sahu SK, Gummadi SN, Manoj N and Aradhyam
GK: Phospholipid scramblases: An overview. Arch Biochem Biophys.
462:103–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nanjundan M, Sun J, Zhao J, Zhou Q, Sims
PJ and Wiedmer T: Plasma membrane phospholipid scramblase 1
promotes EGF-dependent activation of c-Src through the epidermal
growth factor receptor. J Biol Chem. 278:37413–37418. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi HJ, Lui A, Ogony J, Jan R, Sims PJ
and Lewis-Wambi J: Targeting interferon response genes sensitizes
aromatase inhibitor resistant breast cancer cells to
estrogen-induced cell death. Breast Cancer Res. 17:62015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui W, Li SY, Du JF, Zhu ZM and An P:
Silencing phospholipid scramblase 1 expression by RNA interference
in colorectal cancer and metastatic liver cancer. Hepatob Pancreat
Dis. 11:393–400. 2012. View Article : Google Scholar
|
|
17
|
Kuo YB, Chan CC, Chang CA, Fan CW, Hung
RP, Hung YS, Chen KT, Yu JS, Chang YS and Chan EC: Identification
of phospholipid scramblase 1 as a biomarker and determination of
its prognostic value for colorectal cancer. Mol Med. 17:41–47.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Singal AG and El-Serag HB: Hepatocellular
carcinoma from epidemiology to prevention: Translating knowledge
into practice. Clin Gastroenterol Hepatol. 13:2140–2151. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Finn RS: Emerging targeted strategies in
advanced hepatocellular carcinoma. Semin Liver Dis. 33 (Suppl
1):S11–S19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brito AF, Abrantes AM, Tralhão JG and
Botelho MF: Targeting hepatocellular carcinoma: What did we
discover so far? Oncol Rev. 10:3022016.PubMed/NCBI
|
|
22
|
Nakamaki T, Okabe-Kado J,
Yamamoto-Yamaguchi Y, Hino Ki, Tomoyasu S, Honma Y and Kasukabe T:
Role of MmTRA1b/phospholipid scramblase1 gene expression in the
induction of differentiation of human myeloid leukemia cells into
granulocytes. Exp Hematol. 30:421–429. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan CW, Chen CY, Chen KT, Shen CR, Kuo YB,
Chen YS, Chou YP, Wei WS and Chan EC: Blockade of phospholipid
scramblase 1 with its N-terminal domain antibody reduces
tumorigenesis of colorectal carcinomas in vitro and in vivo. J
Transl Med. 10:2542012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan Y, Tian C, Gong Q, Shang L, Zhang Y,
Jin C, He F and Wang J: Interactome map reveals phospholipid
scramblase 1 as a novel regulator of hepatitis B virus × protein. J
Proteome Res. 14:154–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yokoyama A, Yamashita T, Shiozawa E,
Nagasawa A, Okabe-Kado J, Nakamaki T, Tomoyasu S, Kimura F,
Motoyoshi K, Honma Y and Kasukabe T: MmTRA1b/phospholipid
scramblase 1 gene expression is a new prognostic factor for acute
myelogenous leukemia. Leuk Res. 28:149–157. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun J, Zhao J, Schwartz MA, Wang JY,
Wiedmer T and Sims PJ: c-Abl tyrosine kinase binds and
phosphorylates phospholipid scramblase 1. J Biol Chem.
276:28984–28990. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kowalczyk JE, Beręsewicz M, Gajkowska B
and Zabłocka B: Association of protein kinase C delta and
phospholipid scramblase 3 in hippocampal mitochondria correlates
with neuronal vulnerability to brain ischemia. Neurochem Int.
55:157–163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao KW, Li X, Zhao Q, Huang Y, Li D, Peng
ZG, Shen WZ, Zhao J, Zhou Q, Chen Z, et al: Protein kinase Cdelta
mediates retinoic acid and phorbol myristate acetate-induced
phospholipid scramblase 1 gene expression: Its role in leukemic
cell differentiation. Blood. 104:3731–3738. 2004. View Article : Google Scholar : PubMed/NCBI
|
